Ebola Virus Disease in West Africa: 67 New Cases, 19 Deaths
The World Health Organization (WHO) continues to monitor the evolution of the Ebola virus disease (EVD) outbreak in Sierra Leone, Liberia, and Guinea. The current epidemic trend of EVD outbreak in Sierra Leone and Liberia remains serious, with 67 new cases and 19 deaths reported July 15-17, 2014. These include suspect, probable, and laboratory-confirmed cases. The EVD outbreak in Guinea continues to show a declining trend, with no new cases reported during this period. Critical analyses and review of the current outbreak response is being undertaken to inform the process of developing prioritized national operational plans. Effective implementation of the prioritized plans will be vital in reversing the current trend of EVD outbreak, especially in Liberia and Sierra Leone.
WHO has been working with national authorities and partners in the affected countries to analyse and review the current outbreak response. An assessment of the outbreak response conducted in Liberia identified several gaps and challenges. Some of the gaps identified include low coverage of contact tracing; persisting denial and resistance in the community; weak data management; inadequate infection prevention and control practices, especially in peripheral health facilities; and weak leadership and coordination at sub-national levels. Underpinning these challenges were limited financial resources and human technical capacity. Comprehensive mapping of the financial, logistics, and human resource needs will be articulated in the national operational plan under development. This exercise of developing prioritized operational plans is also being conducted in Guinea and Sierra Leone.
Following the call for regional collaboration during the Accra Ministerial meeting, the government and the Ministry of Health of Gambia provided a team of 11 healthcare workers to support outbreak response in Sierra Leone. While this team will contribute the critical human resource needs, the mission will be crucial for enhancing capacity for epidemic preparedness and response in The Gambia. This mission is being supported by UNDP, Gambia, and WHO Sierra Leone.
Efforts are currently ongoing to scale up and strengthen all aspects of the outbreak response in the three countries, including contact tracing, public information and community mobilization, case management and infection prevention and control, and coordination.
WHO does not recommend any travel or trade restrictions be applied to Guinea, Liberia, or Sierra Leone based on the current information available for this event.
As of July 17, 2014, the cumulative number of cases attributed to EVD in the three countries stands at 1,048, including 632 deaths. The distribution and classification of the cases are as follows: Guinea, 410 cases (301 confirmed, 95 probable, and 14 suspected) and 310 deaths (203 confirmed, 95 probable, and 12 suspected); Liberia, 196 cases (76 confirmed, 56 probable, and 64 suspected) and 116 deaths (54 confirmed, 40 probable, and 22 suspected); and Sierra Leone, 442 cases (368 confirmed, 48 probable, and 26 suspected) and 206 deaths (165 confirmed, 35 probable, and 6 suspected).
Source: WHO
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
